{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Duloxetine&page=2", "query": { "intervention": "Duloxetine", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Duloxetine&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T22:57:45.958Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04504812", "title": "A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "Duloxetine", "type": "DRUG" }, { "name": "Intra-Articular Injection", "type": "COMBINATION_PRODUCT" }, { "name": "Nerve Procedure with long acting blocks", "type": "PROCEDURE" }, { "name": "Nerve Procedure with nerve ablation", "type": "PROCEDURE" }, { "name": "Pain Coping Skills Training", "type": "BEHAVIORAL" }, { "name": "Best Practices", "type": "OTHER" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT", "PROCEDURE", "BEHAVIORAL", "OTHER" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1937, "start_date": "2021-02-01", "completion_date": "2025-04-08", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 24, "location_summary": "Sacramento, California • San Diego, California • Aurora, Colorado + 19 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04504812" }, { "nct_id": "NCT00190814", "title": "Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Incontinence, Stress" ], "interventions": [ { "name": "duloxetine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 600, "start_date": "2003-09", "completion_date": "2006-05", "has_results": false, "last_update_posted_date": "2007-01-26", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00190814" }, { "nct_id": "NCT01309945", "title": "Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depression" ], "interventions": [ { "name": "Duloxetine", "type": "DRUG" }, { "name": "Placebo matching with BMS-820836", "type": "DRUG" }, { "name": "BMS-820836", "type": "DRUG" }, { "name": "Placebo matching with Duloxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 889, "start_date": "2011-04", "completion_date": "2013-01", "has_results": false, "last_update_posted_date": "2015-10-12", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 55, "location_summary": "Little Rock, Arkansas • Arcadia, California • Encino, California + 42 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Arcadia", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Los Alamitos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01309945" }, { "nct_id": "NCT00190853", "title": "Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Stress Incontinence" ], "interventions": [ { "name": "Duloxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "18 Years to 75 Years · Female only" }, "enrollment_count": 93, "start_date": "2005-01", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2007-01-26", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Denver, Colorado • West Palm Beach, Florida + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Denver", "state": "Colorado" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Oak Lawn", "state": "Illinois" }, { "city": "Fort Wayne", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00190853" }, { "nct_id": "NCT01000805", "title": "A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Duloxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 528, "start_date": "2009-11", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2012-01-13", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 16, "location_summary": "Beverly Hills, California • Sherman Oaks, California • Jacksonville, Florida + 13 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Sherman Oaks", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000805" }, { "nct_id": "NCT00489411", "title": "Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neurotoxicity", "Pain", "Peripheral Neuropathy", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "duloxetine hydrochloride", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 231, "start_date": "2008-04", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2017-04-26", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 475, "location_summary": "Antioch, California • Berkeley, California • Burlingame, California + 328 more", "locations": [ { "city": "Antioch", "state": "California" }, { "city": "Berkeley", "state": "California" }, { "city": "Burlingame", "state": "California" }, { "city": "Castro Valley", "state": "California" }, { "city": "Castro Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00489411" }, { "nct_id": "NCT00360399", "title": "Identifying Factors That Predict Antidepressant Treatment Response", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression" ], "interventions": [ { "name": "Escitalopram", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" }, { "name": "Cognitive behavioral therapy (CBT)", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 344, "start_date": "2006-08", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-08-30", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00360399" }, { "nct_id": "NCT01070329", "title": "A Study in Depression and Associated Painful Physical Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Duloxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 527, "start_date": "2010-03", "completion_date": "2011-03", "has_results": true, "last_update_posted_date": "2012-02-13", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 32, "location_summary": "Sherman Oaks, California • Cromwell, Connecticut • Fort Lauderdale, Florida + 29 more", "locations": [ { "city": "Sherman Oaks", "state": "California" }, { "city": "Cromwell", "state": "Connecticut" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01070329" }, { "nct_id": "NCT01369095", "title": "Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depression" ], "interventions": [ { "name": "Duloxetine", "type": "DRUG" }, { "name": "Escitalopram", "type": "DRUG" }, { "name": "BMS-820836 Placebo", "type": "DRUG" }, { "name": "BMS-820836", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 976, "start_date": "2011-07", "completion_date": "2013-05", "has_results": false, "last_update_posted_date": "2015-10-12", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Chino, California + 41 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Chino", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01369095" }, { "nct_id": "NCT03315533", "title": "Altering The Transition From Acute to Chronic Pain (ATTAC-Pain)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Musculoskeletal Pain" ], "interventions": [ { "name": "Duloxetine 30 milligrams (MG)", "type": "DRUG" }, { "name": "Duloxetine 60 milligrams (MG)", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rhode Island Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 76, "start_date": "2018-01-19", "completion_date": "2019-04-01", "has_results": false, "last_update_posted_date": "2020-07-08", "last_synced_at": "2026-09-26T22:57:45.958Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT03315533" } ] }